medigraphic.com
ISSN 2078-7170 (Electronic)

2011, Number 1

<< Back Next >>

CorSalud 2011; 3 (1)

Myocardial perfusion scintigraphy in postmenopausal women with angina and angiographically normal epicardial coronary

Valdés MA, Sixto FS, Peix GA

Language: Spanish
References: 30
Page: 4-14
PDF size: 282.49 Kb.


ABSTRACT

Introduction and Objectives: Microvascular angina is common in postmenopausal women. Myocardial ischemia was induced by stress testing, and reports have been published about the relationship between endothelial dysfunction and myocardial perfusion. The objective of this research was to determine whether myocardial ischemia can be evidenced by abnormalities in perfusion and function, as detected by myocardial scintigraphy in women with typical angina, normal coronary angiography and endothelial dysfunction. Methods: 59 women underwent lipid and endothelial function measurements by brachial artery ultrasound, in addition, a 24-hour ECG study (Holter). During the scintigraphy a stress-rest protocol was applied. Patients were divided into two groups according to presence (group I) or absence (group II) of myocardial perfusion defects.Results: 21 patients showed perfusion defects. 57 % of group I exhibited greater endothelial dysfunction. Only twelve patients showed reversible perfusion defects, and 75 % of the cases was associated with a reduction of post-stress left ventricular ejection fraction, greater than 5 %, and regional abnormalities of wall motion. Three patients in group I showed evidence of ischemia compared with four in Group II. Conclusions: The stress-induced ischemia was associated with a reduced post-stress ejection fraction and endothelial dysfunction in the studied women, and no ischemic changes in the Holter were found.


REFERENCES

  1. Panting J, Gatehouse P, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendo-cardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346(25):1948-53.

  2. Johnson BD, Shaw LA, Buchthal SD, Bairey Merz N, Kim HW, Scott KN, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ische-mia Syndrome Evaluation (WISE). Circulation. 2004;109(24):2993-9.

  3. Masci PG, Laclaustra M, Lara JG, Kaski JC. Brachial artery flow-mediated dilation and myo-cardial perfusion in patients with cardiac syn-drome X. Am J Cardiol. 2005; 95(12):1478-80.

  4. Davignon J, Ganz P. Role of endothelial dys-function in atherosclerosis. Circulation. 2004;109 (23 Suppl 1):III-27-32.

  5. Kaski JC, Aldama G, Cosín-Sales J. Cardiac syndrome X: diagnosis, pathogenesis and management. Am J Cardiovasc Drugs. 2004;4(6): 179-94.

  6. Paynter N, Cook N, Everett B, Sesso J, Buring J, Ridker P. Development and Testing of a Risk Prediction Algorithm for Incident Hypertension in Women with Currently Normal Blood Pressure. Circulation. 2008;118:S_1129.

  7. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366(9491):1059-62.

  8. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, et al. Cardio-vascular mortality and non- contraceptive use of estrogen in Women: results from the Lipid Research Clinics Program follow-Up. Circulation. 1987;75(6):1102-9.

  9. Arroyo-Esplieguero R, Mollichelli N, Avanzas P, Zouridakis E, Newey VR, Nassiri DK, et al. Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J. 2003;24(22):2006-11.

  10. Buchthal S, den Hollander J, Bairey N, Rogers W, Pepine C, Reichek N, et al. Abnormal myocar-dial phosporus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342:829-35.

  11. Lanza GA, Crea F. Primary coronary microvas-cular dysfunction. Circulation. 2010;121(21): 2317-25.

  12. Hasdai D, Gibbons R, Holmes D, Higano S, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96:3390-5.

  13. Schindler T, Nitzsche E, Magosaki N, Brink I, Mix M, Olschewski M, et al. Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium-dependent vasoreactivity of the coronary micro-circulation. Heart. 2003;89(5):517-26.

  14. Vermeltfoort I, Bondarenko O, Raijmakers P, Odekerken D, Kuijper A, Zwijnenburg A, et al. Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. Eur Heart J. 2007; 28(13):1554-8.

  15. Hale SL, Kloner RA. Acetaminophen and myocardial stunning after transient ischemia in rabbits hearts. J Cardiovasc Pharmacol Ther. 2005;10(2):121-9.

  16. Rinaldi CA, Hall RJ. Myocardial stunning and hibernation in clinical practice. Int J Clin Pract. 2000;54(10):659-64.

  17. Ambrosio G, Tritto I. Clinical manifestation of myocardial stunning. Coron Artery Dis. 2001; 12:357-61.

  18. Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Post-ischemic stunning can affect left ventricular ejection frac-tion and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol. 1997; 30(7):1641-8.

  19. Borges-Neto S, Javaid A, Shaw LK, Kong DF, Hanson MV, Pagnanelli RA, et al. Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol. Radiology. 2000;215(2):529-33.

  20. Wheat JM, Currie GM. Rest vs. stress ejection fraction on gated myocardial perfusion SPECT. J Nucl Med Technol. 2005;33(4):218-23.

  21. Bugiardini R. Normal coronary arteries: clinical implications and further classification. Herz. 2005; 30(1):3-7.

  22. Tanaka R, Nakamura T, Kumamoto H, Miura M, Hirabayashi K, Okamato N, et al. Ann Nucl Med. 2003;17(1):53-60.

  23. Santana CA, Garcia EV, Vansant JP, Krawc-zynska EG, Folks RD, Cooke CD, et al. Gated stress-only 99mTc myocardial perfusion SPECT imaging accurately assesses coronary artery disease. Nucl Med Commun. 2003;24(3):241-9.

  24. Paul AK, Hasegawa S, Yoshioka J, Mu X, Maruyama K, Kusuoka H, et al. Characteristics of regional myocardial stunning after exercise in gated myocardial SPECT. J Nucl Cardiol. 2002;9: 388-94.

  25. Bestetti A, Di Leo C, Alessi A, Triulzi A, Tagliabue L, Tarolo GL. Post-stress end-systolic left ventricular dilation: a marker of endocardial post-ischemic stunning. Nucl Med Commun. 2001; 22(6):685-93.

  26. Arrighi JA, Burg M, Cohen IS, Kao AH, Pfau S, Caulin-Glaser T, et al. Myocardial blood-flow response during mental stress in patients with coronary artery disease. Lancet. 2000;356(9226): 310-11.

  27. Mendelsohn ME, Karas RH. The protective effects of estrogens on the cardiovascular sys-tem. N Engl J Med. 1999;340(23):1801-11.

  28. Rosen SD, Paulesu E, Wise RJ, Camici PG. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart. 2002;87(6):513-9.

  29. Kaski JC. Cardiac syndrome X in women: the role of oestrogen deficiency. Heart. 2006;92(Suppl 3):5-9.

  30. Sestito A, Bruno I, Di Monaco A, Sgueglia G, Giordano A, Lanza G, et al. Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X. Circulation. 2007; 116:II_344-5.




2020     |     www.medigraphic.com